home / stock / repl / repl news


REPL News and Press, Replimune Group Inc. From 06/02/24

Stock Information

Company Name: Replimune Group Inc.
Stock Symbol: REPL
Market: NASDAQ
Website: replimune.com

Menu

REPL REPL Quote REPL Short REPL News REPL Articles REPL Message Board
Get REPL Alerts

News, Short Squeeze, Breakout and More Instantly...

REPL - Learn to Evaluate (REPL) using the Charts

2024-06-02 15:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

REPL - PLAB, ARRY and SYM are among after hour movers

2024-05-24 16:58:54 ET Gainers: Photronics ( PLAB ) +6% . Replimune Group  ( REPL ) +4% . Caribou Biosciences ( CRBU ) +3% . Symbotic  ( SYM ) +3% . Arhaus ( ARHS ) +3% . Losers: OneMedNet  ( ONMD ) -...

REPL - Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of oncolytic immunotherapies, today announced multiple presentations at the 2024 American Society of Clinical Oncology (ASCO)...

REPL - Replimune: Continuing To Justify The Bear Thesis (For Now)

2024-05-22 09:47:37 ET Summary Replimune Group, Inc.'s stock has fallen 35% in 2024, and an inflection point is not expected yet. The company is working on RP1, an oncolytic virus therapy, and has shared positive results from their ARTACUS trial. Replimune plans to submit a BL...

REPL - REPL Stock Earnings: Replimune Group Misses EPS for Q4 2024

2024-05-16 13:53:07 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Replimune Group (NASDAQ: REPL ) just reported results for the fourth quarter of 2024. Replimune Group reported earnings per share of -82 cents. This was below the analyst ...

REPL - Replimune Group GAAP EPS of -$3.24 misses by $0.07

2024-05-16 09:18:03 ET More on Replimune Group Seeking Alpha’s Quant Rating on Replimune Group Historical earnings data for Replimune Group Financial information for Replimune Group Read the full article on Seeking Alpha For further details see...

REPL - Replimune Reports Fiscal Fourth Quarter and Year Ended 2024 Financial Results and Provides Corporate Update

Twelve-month primary analysis results by independent central review from the IGNYTE clinical trial of RP1 (vusolimogene oderparepvec) in anti-PD1 failed melanoma expected Q2 2024 Recent Type C CMC meeting with the U.S. Food and Drug Administration (FDA) supports IGNYTE Biologics Lic...

REPL - Expected US Company Earnings on Thursday, May 16th, 2024

JD.com Inc. (JD) is expected to report $0.56 for Q1 2024 Volkswagen AG (VLKAF) is expected to report for Q1 2024 CalAmp Corp. (CAMP) is expected to report for Q4 2024 Sonic Foundry Inc. (SOFO) is expected to report for Q2 2024 Moatable Inc ADR (R2RS:MU) is expected to report for Q...

REPL - (REPL) Pivots Trading Plans and Risk Controls

2024-04-24 04:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

REPL - (REPL) Investment Analysis

2024-04-14 06:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10